![]() ![]() 1 Many more patients will experience rising prostate-specific antigen (PSA) levels following local therapy, a condition known as biochemical recurrence (BCR Figure 1). Antonarakis, MD, Assistant Professor of Oncology, Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, MD 21231 Phone: 44 Fax: 41 E-mail: than 12% of the 241,700 men expected to have been diagnosed with prostate cancer in the United States in 2012 will die from this disease. Paller and Antonarakis are Assistant Professors of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, in Baltimore, Maryland.Īddress correspondence to: Emmanuel S. Clinical Advances in Hematology & OncologyĬhanning J.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |